When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OptiNose's XHANCE net sales showed good traction in FY2020 despite the considerable headwinds from the COVID-19 pandemic.
With two Phase 3b trials set in the near future for another XHANCE indication, a novel exhalation delivery system, and trading at 2.5x 2021E net revenue, OptiNose merited investigation.
A full investment analysis and recommendation follow in the paragraphs below.